title: The effect of highly purified eicosapentaenoic acid in patients with psoriasis.
authors.affiliation: 2nd Department of Internal Medicine, Chiba University School of Medicine, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Terano
authors.forename: T
authors.initials: T
authors.lastname: Kojima
authors.forename: A
authors.initials: A
authors.lastname: Seya
authors.forename: E
authors.initials: E
authors.lastname: Tanabe
authors.forename: A
authors.initials: A
authors.lastname: Hirai
authors.forename: H
authors.initials: H
authors.lastname: Makuta
authors.forename: A
authors.initials: A
authors.lastname: Ozawa
authors.forename: T
authors.initials: T
authors.lastname: Fujita
authors.forename: Y
authors.initials: Y
authors.lastname: Tamura
authors.forename: S
authors.initials: S
authors.lastname: Okamoto
mesh_terms: D000328:Adult; D000368:Aged; D001094:Arachidonate 5-Lipoxygenase / Q000097:blood; D000001:Calcimycin / Q000494:pharmacology; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D004890:Erythema; D005260:Female; D005966:Glucuronidase / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D007975:Leukotriene B4 / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects* / Q000201:enzymology; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology; D012867:Skin / Q000503:physiopathology
chemical_list: D007975:Leukotriene B4; D000001:Calcimycin; D015118:Eicosapentaenoic Acid; D001094:Arachidonate 5-Lipoxygenase; D005966:Glucuronidase